Skip to content

A retrospective cohort clinical study evaluating the impact of inhalation anesthesia and intravenous anesthesia on the occurrence of adverse events in adult smoke disease blood flow reconstruction surgery

The impact of inhalation anesthesia and intravenous anesthesia on the occurrence of adverse events in adult smoke disease blood flow reconstruction surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088291
Enrollment
Unknown
Registered
2024-08-15
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya Disease

Interventions

Inhalation anesthesia group:None

Sponsors

Fudan University, Huashan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Neurosurgery DSA examination confirmed that the patient is in Suzuki stage I to VI and has undergone intracranial and extracranial vascular reconstruction treatment for Moyamoya disease under general anesthesia. ? Age range: 18-65 years old, gender not limited; ? Preoperative DSA examination and CT or MRI evaluation of the patient's brain condition to guide the surgery; ? The perioperative data is complete without any obvious omissions or missing items.

Exclusion criteria

Exclusion criteria: ? Research participants are not allowed to participate in at least 2 clinical studies simultaneously; ? The patient has severe cardiovascular disease (such as myocardial infarction, heart failure, etc.), severe liver and kidney dysfunction, as well as coexisting malignant tumors, severe mental illness, pregnancy or lactation;

Design outcomes

Primary

MeasureTime frame
Stroke incidence rate 7 days after surgery;

Secondary

MeasureTime frame
Hyperperfusion syndrome;Postoperative incidence of epilepsy;Postoperative changes in neurological function;

Countries

China

Contacts

Public ContactCheng Yifei

Fudan University, Huashan Hospital

181492021@qq.com+86 159 5513 5377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026